Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Estimates have been rising after the company delivered better than expected third quarter results. It is a Zacks #2 Rank (Buy).
The company also pays a divdend that yields a stellar 7.9%. Valuation is attractive too, with shares trading at less than 11x forward earnings.
REIT
Omega Healthcare is a real estate investment trust (REIT) that provides financing and capital to the long-term healthcare industry across the United States.
The company owns or holds mortgages on 399 skilled nursing facilities, assisted living facilities and other specialty hospitals in 35 states, which are operated by 49 third-party healthcare companies.
It is headquartered in Hunt Valley, Maryland and has a market cap of $2.1 billion.
7.9% Dividend
As a REIT, Omega Healthcare pays out the majority of its earnings to shareholders through dividends to avoid paying tax on that money. It currently yields a whopping 7.9%.
As you can see, the company has been steadily increasing its dividend over the last several years:
On January 13, the company announced an increase in its quarterly dividend to 41 cents per share. This marked the 6th dividend increase since early 2010.
Third Quarter Results
Omega Healthcare also reported better than expected results for the third quarter. Funds from operation (FFO) per share came in at 48 cents, beating the Zacks Consensus Estimate of 46 cents. It was a 9% increase over the same quarter in 2010.
Total revenue rose 4% to $72.8 million, ahead of the Zacks Consensus Estimate of $71.0 million. This was mostly driven by a 4% increase in rental income.
Total operating expenses declined from 53.1% of revenue to 40.4% due to lower general & administrative and depreciation expenses.
Outlook
Analysts raised their estimates for 2012 following better than expected Q3 results. This sent the stock to a Zacks #2 Rank (Buy).
The Zacks Consensus Estimate for 2011 is $1.79, representing 8% growth over 2010. The 2012 consensus estimate is currently $1.95, corresponding with 9% FFO growth.
Reasonable Valuation
The valuation picture looks very reasonable for OHI. Shares trade at just 10.6x 12-month forward FFO, below the industry median of 13.6x and its historical median of 11.2x.
Its price to book ratio of 2.4 is in-line with its 5-year median.
The Bottom Line
With rising estimates, solid growth projections, a 7.9% dividend yield and reasonable valuation, Omega Healthcare offers investors attractive total return potential.
Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research and Co-Editor of the Reitmeister Value Investor.
Read the full Snapshot Report on OHI